CD8A and diabetes mellitus: IGRP 206-214 reactive CD8+ T cells were reduced in TIP-1 mice at 12-14 weeks; but ongoing tolerance to PIns1 did not prevent development of diabetes onset in TIP-1/8.3 mice.